Primary Image

smart phone

Clinical Trial

Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone-Based Technology and E-coaching: A Proof-of-Concept SMART-Design Study

Contact

Anushua Banerjee abanerjee@sralab.org

Objective

The purpose of this study is to evaluate changes in physical activity using a customized, interactive exercise app and e-coaching compared to a more traditional exercise app. This study primarily occurs remotely, however, there are three visits to Shirley Ryan 小恩雅. Participants will complete an initial in-person visit that may last up to 5 hours. Then they will be provided customized exercises to complete over the next 6 months using either the interactive or more traditional smartphone app (randomly assigned). Only two more in-person visits at 3 and 6 months. Up to weekly video conference coaching sessions may be added in the last 3 months. Participation is expected to last 6 months. Participants will receive compensation.

This study is funded by the national Institutes of Disability, Independent Living and Rehabilitation Research, and is a project of the Midwest Regional Spinal Cord Injury Care System at Shirley Ryan 小恩雅. 

Who Can Participate

  • Be at least 1 year post spinal cord injury diagnosis 
  • Age 18-80 years
  • Not meeting SCI exercise guidelines
  • Willing to use study apps on a personal mobile device
  • No surgery or trauma last 3 months
  • Not enrolled in a structured exercise program in the past 3 months

Compensation

Participants will receive $100 after completing a 2-week trial of the app, completion of surveys and a possible interview on their experience.

Age Range

18 - 80

Apply for this Trial

Your information will not be published.

All fields are required.

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan 小恩雅. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all